Mabpharm Limited (02181) Publishes Monthly Return for November 2025

Bulletin Express

2025/12/03

Mabpharm Limited (02181) reported that its total authorized share capital remained at 50,000,000,000 ordinary shares as of November 30, 2025, carrying a par value of USD 0.0001 each, for a total of USD 5,000,000. The issued share capital stood unchanged from the previous month, with 4,124,080,000 ordinary shares in issue and no treasury shares reported.

The share option scheme, previously approved on August 10, 2018, maintained 72,670,876 outstanding share options with no new issuances or exercises during the period. The company indicated no movement in warrants, convertibles, or other share issuance arrangements during November 2025. The disclosure was submitted by Secretary Tsang Ho Yin on December 3, 2025.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1156374522"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156374522\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156374522?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-03 16:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156374522","market":"us","top_or_hot":-1,"title":"Mabpharm Limited (02181) Publishes Monthly Return for November 2025","media":"Bulletin Express","content":"<p>Mabpharm Limited (02181) reported that its total authorized share capital remained at 50,000,000,000 ordinary shares as of November 30, 2025, carrying a par value of USD 0.0001 each, for a total of USD 5,000,000. The issued share capital stood unchanged from the previous month, with 4,124,080,000 ordinary shares in issue and no treasury shares reported.</p>\n<p>The share option scheme, previously approved on August 10, 2018, maintained 72,670,876 outstanding share options with no new issuances or exercises during the period. The company indicated no movement in warrants, convertibles, or other share issuance arrangements during November 2025. The disclosure was submitted by Secretary Tsang Ho Yin on December 3, 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mabpharm Limited (02181) Publishes Monthly Return for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMabpharm Limited (02181) Publishes Monthly Return for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-03 16:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mabpharm Limited (02181) reported that its total authorized share capital remained at 50,000,000,000 ordinary shares as of November 30, 2025, carrying a par value of USD 0.0001 each, for a total of USD 5,000,000. The issued share capital stood unchanged from the previous month, with 4,124,080,000 ordinary shares in issue and no treasury shares reported.</p>\n<p>The share option scheme, previously approved on August 10, 2018, maintained 72,670,876 outstanding share options with no new issuances or exercises during the period. The company indicated no movement in warrants, convertibles, or other share issuance arrangements during November 2025. The disclosure was submitted by Secretary Tsang Ho Yin on December 3, 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02181","symbol_name":"迈博药业-B","start_time":0,"source_url":"","article_id":"1156374522","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156374522","pubTimestamp":1764751767,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Mabpharm Limited (02181) reported that its total authorized share capital remained at 50,000,000,000 ordinary shares as of November 30, 2025, carrying a par value of USD 0.0001 each, for a total of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02181":"迈博药业-B"},"translate_title":"迈博药业(02181)公布2025年11月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02181":1},"content_text":"Mabpharm Limited (02181) reported that its total authorized share capital remained at 50,000,000,000 ordinary shares as of November 30, 2025, carrying a par value of USD 0.0001 each, for a total of USD 5,000,000. The issued share capital stood unchanged from the previous month, with 4,124,080,000 ordinary shares in issue and no treasury shares reported.\nThe share option scheme, previously approved on August 10, 2018, maintained 72,670,876 outstanding share options with no new issuances or exercises during the period. The company indicated no movement in warrants, convertibles, or other share issuance arrangements during November 2025. The disclosure was submitted by Secretary Tsang Ho Yin on December 3, 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}